MXPA03010598A - Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales. - Google Patents
Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales.Info
- Publication number
- MXPA03010598A MXPA03010598A MXPA03010598A MXPA03010598A MXPA03010598A MX PA03010598 A MXPA03010598 A MX PA03010598A MX PA03010598 A MXPA03010598 A MX PA03010598A MX PA03010598 A MXPA03010598 A MX PA03010598A MX PA03010598 A MXPA03010598 A MX PA03010598A
- Authority
- MX
- Mexico
- Prior art keywords
- bacteria
- gram
- lactic acid
- immune responses
- lipoteichoic
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 8
- 241000894006 Bacteria Species 0.000 title abstract 6
- 239000002253 acid Substances 0.000 title abstract 4
- 235000014655 lactic acid Nutrition 0.000 title abstract 4
- 239000004310 lactic acid Substances 0.000 title abstract 4
- 230000028993 immune response Effects 0.000 title abstract 3
- 241000192125 Firmicutes Species 0.000 title abstract 2
- 230000001404 mediated effect Effects 0.000 title abstract 2
- 230000001717 pathogenic effect Effects 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 208000034309 Bacterial disease carrier Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 229940023486 oral product Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 229940025703 topical product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
Abstract
La invencion se refiere a una composicion para modular las respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales y/o sus derivados, que comprende acido lipoteicoico de bacterias de acido lactico como un ingrediente activo. Tambien se refiere al uso de un acido lipoteicoico de bacterias de acido lactico como un ingrediente activo y/o bacterias de acido lactico que lo producen y/o su sobrenadante de cultivo, en la elaboracion de un medicamento, un producto oral o topico para aplicaciones cosmeticas, dermatologicas u oftalmologicas, una composicion alimenticia o de alimento para mascotas para modular la colonizacion de bacterias, respuestas inmunitarias y disminuir los procesos inflamatorios asociados con enfermedad e infeccion mediada por bacterias en el tracto gastrointestinal, hueso, piel, ojo, oido, pulmon y cavidad oral. La invencion tambien se refiere a acido lipoteicoico seleccionado del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01201958A EP1260227A1 (en) | 2001-05-23 | 2001-05-23 | Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| PCT/EP2002/004436 WO2002094296A1 (en) | 2001-05-23 | 2002-04-23 | Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA03010598A true MXPA03010598A (es) | 2004-03-09 |
| MX260807B MX260807B (es) | 2008-09-25 |
Family
ID=8180365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010598 MX260807B (es) | 2001-05-23 | 2002-04-23 | Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales. |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20040147010A1 (es) |
| EP (2) | EP1260227A1 (es) |
| JP (1) | JP4738717B2 (es) |
| KR (1) | KR20040018375A (es) |
| CN (1) | CN100502888C (es) |
| AT (1) | ATE394111T1 (es) |
| AU (1) | AU2002338873B8 (es) |
| BR (1) | BR0209975A (es) |
| CA (1) | CA2449403C (es) |
| DE (1) | DE60226436D1 (es) |
| DK (1) | DK1395269T3 (es) |
| ES (1) | ES2305256T3 (es) |
| IN (1) | IN2003DE02242A (es) |
| MX (1) | MX260807B (es) |
| NO (1) | NO20035187L (es) |
| PL (1) | PL366455A1 (es) |
| PT (1) | PT1395269E (es) |
| RU (1) | RU2320356C2 (es) |
| SG (1) | SG101083A1 (es) |
| WO (1) | WO2002094296A1 (es) |
| ZA (1) | ZA200309821B (es) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2408573A (en) * | 2003-11-25 | 2005-06-01 | Univ Leicester | Assay for the interaction of L-Ficolin with lipoteichoic acid |
| EP1706126A4 (en) * | 2003-12-04 | 2009-07-01 | Biofilms Strategies Inc | METHODS AND COMPOSITIONS FOR PREVENTING FORMATION OF BIOFILMS, REDUCTION OF EXISTING BIOFILMS, AND REDUCTION OF BACTERIA POPULATIONS |
| US7709032B2 (en) | 2003-12-05 | 2010-05-04 | Toyo R&D Inc. | Anti-allergic agent containing both ground lotus and/or extract and lactic acid bacterium |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| AU2005227234B2 (en) | 2004-03-04 | 2008-09-04 | E-L Management Corporation | Skin treatment method with lactobacillus extract |
| US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| JP4726109B2 (ja) * | 2005-02-10 | 2011-07-20 | 昭和電工株式会社 | 皮膚外用剤、それを用いる皮膚有害微生物の付着予防方法及び増殖防止方法 |
| US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| AR053805A1 (es) | 2005-05-31 | 2007-05-23 | Iams Company | Bifidobacterias probioticas para felinos |
| EP2261323A1 (en) | 2005-05-31 | 2010-12-15 | The Iams Company | Feline probiotic lactobacilli |
| RU2436581C2 (ru) | 2007-02-01 | 2011-12-20 | Дзе Иамс Компани | Способ уменьшения воспаления и снижения стресса у млекопитающего |
| WO2008106763A1 (en) * | 2007-03-08 | 2008-09-12 | The Governors Of The University Of Alberta | Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| EP2147091A4 (en) * | 2007-04-24 | 2010-12-08 | Kemin Ind Inc | ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY WITH LACTOBACILLUS JOHNSONII D115 LARGE SPECTRUM |
| JP5225652B2 (ja) * | 2007-10-29 | 2013-07-03 | 雪印メグミルク株式会社 | アディポネクチン分泌促進及び／又は減少抑制剤 |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| EP2140772A1 (en) * | 2008-07-03 | 2010-01-06 | Nestec S.A. | Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| RU2011129693A (ru) * | 2008-12-16 | 2013-01-27 | Нестек С.А. | Композиции и способы улучшения здоровья полости рта |
| WO2010130662A1 (en) * | 2009-05-11 | 2010-11-18 | Nestec S.A. | LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| JP2013502456A (ja) * | 2009-08-26 | 2013-01-24 | アールエヌエー アイエヌシー | リポタイコ酸由来の糖脂質及びこれを含む組成物 |
| WO2012118535A1 (en) * | 2011-03-01 | 2012-09-07 | Quorum Innovations, Llc | Materials and methods for treating conditions associated with pathogenic biofilm |
| AU2012222827A1 (en) * | 2011-03-03 | 2013-10-03 | The Governors Of The University Of Alberta | Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| US20130089638A1 (en) * | 2011-10-11 | 2013-04-11 | Mead Johnson Nutrition Company | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes |
| EP2589387A1 (en) * | 2011-11-04 | 2013-05-08 | Lunamed AG | Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain |
| CN102399733B (zh) * | 2011-12-14 | 2014-07-09 | 北京大北农科技集团股份有限公司 | 约氏乳杆菌及其菌剂、应用和预混料 |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| US9399048B2 (en) * | 2014-03-05 | 2016-07-26 | Asian Probiotics And Prebiotics Ltd | Lactic acid bacteria and its applications in immunomodulation and anti-inflammation |
| CN104161775A (zh) * | 2014-05-29 | 2014-11-26 | 浙江大学宁波理工学院 | 来自丁酸梭菌的脂磷壁酸在调节水产动物免疫应答中的用途 |
| CN104161776A (zh) * | 2014-05-29 | 2014-11-26 | 浙江大学宁波理工学院 | 来自丁酸梭菌的脂磷壁酸及其调节畜禽免疫应答的用途 |
| ES2668934T3 (es) | 2014-12-23 | 2018-05-23 | 4D Pharma Research Limited | Polipéptido pirin y modulación inmune |
| JP6271093B1 (ja) | 2014-12-23 | 2018-01-31 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | 免疫調節 |
| MX2017010321A (es) | 2015-02-13 | 2017-12-07 | Mars Inc | Sistema de alimentacion para mascotas. |
| ES2753779T3 (es) | 2015-06-15 | 2020-04-14 | 4D Pharma Res Ltd | Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes |
| DK3650033T3 (da) | 2015-06-15 | 2022-04-11 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
| PL3307288T3 (pl) | 2015-06-15 | 2019-12-31 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| CA3005781C (en) | 2015-11-20 | 2019-01-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| ME03487B (me) | 2016-03-04 | 2020-01-20 | 4D Pharma Plc | Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| US10874700B2 (en) | 2016-03-31 | 2020-12-29 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| WO2017173240A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| CN106236826A (zh) * | 2016-08-12 | 2016-12-21 | 福建万亿店中店电子商务有限责任公司 | 一种用于阴道疾病辅助治疗的乳酸菌磷壁酸凝胶 |
| US11564879B2 (en) | 2016-11-23 | 2023-01-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| ES2877726T3 (es) | 2017-05-22 | 2021-11-17 | 4D Pharma Res Ltd | Composiciones que comprenden cepas bacterianas |
| MA41708A (fr) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| KR102205829B1 (ko) * | 2017-06-14 | 2021-01-21 | 기초과학연구원 | 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체 |
| BR112019026677A2 (pt) | 2017-06-14 | 2020-06-30 | 4D Pharma Research Limited | composições compreendendo cepas bacterianas |
| EP3638271B1 (en) | 2017-06-14 | 2020-10-14 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| HUE053488T2 (hu) | 2017-06-14 | 2021-06-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| CN111053789A (zh) * | 2019-11-26 | 2020-04-24 | 湖南营养树生物科技有限公司 | 调节免疫系统的方法和组合物 |
| AU2020412749A1 (en) * | 2019-12-27 | 2022-06-16 | Biopolis, S.L. | Uses of lipoteichoic acid from Bifidobacteria |
| KR102325947B1 (ko) * | 2020-02-05 | 2021-11-15 | 주식회사 에이치이엠파마 | 신규한 락토바실러스 사케이 hem224 균주, 및 상기 균주 또는 이의 배양물을 포함하는 염증 또는 천식의 치료용 조성물 |
| EP4152948A4 (en) * | 2020-06-26 | 2024-08-07 | Zivo Bioscience Inc | IMMUNE PRIMING TO ACCELERATE/ENHANCE THE IMMUNE RESPONSE BY ADMINISTRATION OF A NATURAL IMMUNE MODULATOR |
| JP2023179810A (ja) * | 2020-11-13 | 2023-12-20 | 味の素株式会社 | ラクトコッカス・ラクチス、ラクトバチルス属に属する微生物、又はこれらの混合微生物を含有する生菌剤及びその製造方法 |
| JP2023128590A (ja) * | 2022-03-03 | 2023-09-14 | 株式会社アルソア慧央グループ | 腸管免疫賦活剤、ＩｇＡ産生促進剤及び遺伝子発現促進剤 |
| CN115068510A (zh) * | 2022-05-24 | 2022-09-20 | 宁波大学 | 一种乳杆菌脂磷壁酸的提取方法及其抗炎活性应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4678773A (en) | 1983-08-26 | 1987-07-07 | Chugai Seiyaku Kabushiki Kaisha | Antitumor agent |
| JPS6048929A (ja) * | 1983-08-26 | 1985-03-16 | Chugai Pharmaceut Co Ltd | 抗腫瘍剤 |
| JPS6048928A (ja) * | 1983-08-26 | 1985-03-16 | Chugai Pharmaceut Co Ltd | Ｔνｆ誘起剤 |
| JPS61275217A (ja) * | 1985-05-29 | 1986-12-05 | Yakult Honsha Co Ltd | グラム陰性桿菌感染症防御剤 |
| US5804179A (en) * | 1985-12-31 | 1998-09-08 | Research Corporation Technologies, Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
| DE3817762A1 (de) * | 1988-05-26 | 1989-11-30 | Sanum Kehlbeck Gmbh & Co Kg | Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben |
| ES2111625T3 (es) * | 1992-07-06 | 1998-03-16 | Nestle Sa | Agente antigastritis. |
| WO1994020115A2 (en) * | 1993-03-10 | 1994-09-15 | Miles, Inc. | Hyaluronic acid used as a cancer treatment |
| US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
| JP3489930B2 (ja) * | 1996-03-08 | 2004-01-26 | 株式会社ヤクルト本社 | がん予防食品 |
| DE69733594T2 (de) * | 1996-07-09 | 2005-11-03 | Société des Produits Nestlé S.A. | Verfahren zur Sprühtrocknung |
| DE29724816U1 (de) * | 1997-01-09 | 2004-07-22 | Société des Produits Nestlé S.A. | Probiotik enthaltendes Getreideprodukt |
| US5998482A (en) * | 1997-11-10 | 1999-12-07 | David; Sunil A. | Use of synthetic polycationic amphiphilic substances with fatty acid or hydrocarbon substituents as anti-sepsis agents |
| JP3046303B1 (ja) * | 1999-06-24 | 2000-05-29 | 明治乳業株式会社 | Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品 |
| DE19963420A1 (de) * | 1999-12-28 | 2001-07-12 | Sebo Gmbh | Gewinnung von biologischen Komponenten aus Körperflüssigkeiten |
-
2001
- 2001-05-23 EP EP01201958A patent/EP1260227A1/en not_active Withdrawn
-
2002
- 2002-04-23 KR KR20037015185A patent/KR20040018375A/ko not_active Application Discontinuation
- 2002-04-23 JP JP2002591013A patent/JP4738717B2/ja not_active Expired - Fee Related
- 2002-04-23 CA CA2449403A patent/CA2449403C/en not_active Expired - Fee Related
- 2002-04-23 PL PL02366455A patent/PL366455A1/xx not_active IP Right Cessation
- 2002-04-23 PT PT02742909T patent/PT1395269E/pt unknown
- 2002-04-23 EP EP02742909A patent/EP1395269B1/en not_active Expired - Lifetime
- 2002-04-23 WO PCT/EP2002/004436 patent/WO2002094296A1/en active IP Right Grant
- 2002-04-23 BR BR0209975-6A patent/BR0209975A/pt not_active Application Discontinuation
- 2002-04-23 ES ES02742909T patent/ES2305256T3/es not_active Expired - Lifetime
- 2002-04-23 MX MXPA03010598 patent/MX260807B/es active IP Right Grant
- 2002-04-23 RU RU2003136828/15A patent/RU2320356C2/ru not_active IP Right Cessation
- 2002-04-23 DE DE60226436T patent/DE60226436D1/de not_active Expired - Lifetime
- 2002-04-23 AT AT02742909T patent/ATE394111T1/de active
- 2002-04-23 AU AU2002338873A patent/AU2002338873B8/en not_active Ceased
- 2002-04-23 US US10/478,079 patent/US20040147010A1/en not_active Abandoned
- 2002-04-23 SG SG200306895A patent/SG101083A1/en unknown
- 2002-04-23 CN CNB02810479XA patent/CN100502888C/zh not_active Expired - Fee Related
- 2002-04-23 DK DK02742909T patent/DK1395269T3/da active
-
2003
- 2003-11-21 NO NO20035187A patent/NO20035187L/no not_active Application Discontinuation
- 2003-12-18 ZA ZA200309821A patent/ZA200309821B/xx unknown
- 2003-12-23 IN IN2242DE2003 patent/IN2003DE02242A/xx unknown
-
2008
- 2008-10-07 US US12/246,991 patent/US8329190B2/en not_active Expired - Fee Related
-
2013
- 2013-08-15 US US13/967,936 patent/US20140056927A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60226436D1 (de) | 2008-06-19 |
| ATE394111T1 (de) | 2008-05-15 |
| AU2002338873B8 (en) | 2008-05-08 |
| AU2002338873B2 (en) | 2008-04-10 |
| EP1260227A1 (en) | 2002-11-27 |
| ZA200309821B (en) | 2005-03-18 |
| PL366455A1 (en) | 2005-02-07 |
| MX260807B (es) | 2008-09-25 |
| WO2002094296A1 (en) | 2002-11-28 |
| IN2003DE02242A (en) | 2006-01-20 |
| US8329190B2 (en) | 2012-12-11 |
| BR0209975A (pt) | 2004-04-06 |
| US20040147010A1 (en) | 2004-07-29 |
| CA2449403A1 (en) | 2002-11-28 |
| ES2305256T3 (es) | 2008-11-01 |
| RU2320356C2 (ru) | 2008-03-27 |
| CN100502888C (zh) | 2009-06-24 |
| US20090142375A1 (en) | 2009-06-04 |
| RU2003136828A (ru) | 2005-03-10 |
| AU2002338873A1 (en) | 2002-12-03 |
| CA2449403C (en) | 2011-11-15 |
| NO20035187L (no) | 2004-01-05 |
| JP2005500267A (ja) | 2005-01-06 |
| KR20040018375A (ko) | 2004-03-03 |
| EP1395269A1 (en) | 2004-03-10 |
| SG101083A1 (en) | 2006-02-28 |
| NO20035187D0 (no) | 2003-11-21 |
| US20140056927A1 (en) | 2014-02-27 |
| JP4738717B2 (ja) | 2011-08-03 |
| DK1395269T3 (da) | 2008-08-04 |
| EP1395269B1 (en) | 2008-05-07 |
| CN1525863A (zh) | 2004-09-01 |
| PT1395269E (pt) | 2008-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03010598A (es) | Acido lipoteicoico de bacterias de acido lactico y su uso para modular respuestas inmunitarias inducidas por bacterias gram-negativas, bacterias gram-positivas patogenas potenciales. | |
| Sekhar et al. | Topical application/formulation of probiotics: will it be a novel treatment approach for diabetic foot ulcer? | |
| MXPA01013239A (es) | Combinacion de bacterias de acido lactico y su uso para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias. | |
| CA2688736C (en) | Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology | |
| AU2003212265A1 (en) | Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations | |
| ATE407687T1 (de) | Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids | |
| HUP9904308A2 (hu) | A mupirocin alkalmazása a nasopharynxnak patogén organizmusokkal történő kolonizációjához társuló bakteriális fertőzések kezelésére szolgáló gyógyszerkészítmény előállítására | |
| BR0113861A (pt) | Derivados de ácidos 3-(heteroaril acetamido)-2-oxo-azetidina-1-sulfÈnicos como agentes antibacterianos | |
| WO2012017349A3 (en) | Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate | |
| Coenye et al. | Biofilms in skin infections: Propionibacterium acnes and acne vulgaris | |
| BRPI0413509A (pt) | uso de antibióticos de quinolona | |
| Gichki et al. | HEALING EFFECTS OF NATURAL HONEY ON ORAL MINOR APTHOUS ULCERS AMONG DENTAL PATIENTS IN QUETTA. | |
| GB0114672D0 (en) | Pharmaceutical formulations and methods of medical treatment | |
| Das et al. | Biofilm formation by pathogenic bacteria: the role of quorum sensing and physical-chemical interactions | |
| Belal | Relevance of bacterial normal flora in antimicrobial resistance and how to overcome this resistance | |
| de Cássia Oliveira et al. | Bacteriophage Isolation from Denture Biofilm | |
| Rivis et al. | Antagonistic activity of Bacillus probiotics against bacteria isolates of oral cavity of patients with periodontitis | |
| Zhamakochyan et al. | Chronic tonsillitis. The role of probiotics in the completion of the inflammatory process. | |
| WO2022184763A8 (en) | Use of galacto-oligosaccharides for providing skin care benefits | |
| CN111479569A (zh) | 氯唑西林抑制/预防生物膜形成的用途 | |
| Sumida et al. | Effectiveness and clinical applications of a safe edible antimicrobial peptide produced by lactic acid bacteria | |
| Snowden | Bacterial biofilm formation and immune evasion mechanisms | |
| Hassan et al. | The Increasing importance of Normal Flora Commensals in Health or Potentially Pathogens for Disease | |
| TH112254A (th) | วิธีการสำหรับการป้องกันหรือการบำบัดการติดเชื้อทางเดินหายใจและหูชั้นกลางอักเสบเฉียบพลันในทารก | |
| CN102771783A (zh) | 26菌维他 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |